10x Genomics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

10x Genomics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $642.82 million for the year ending 2025.

  • 10x Genomics, Inc. showed an increase of +5.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from 10x Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), 10x Genomics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 339.3%.
  • Historical annual values: Fiscal year 2025: $642.82 million | Fiscal year 2024: $610.79 million | Fiscal year 2023: $618.73 million | Fiscal year 2022: $516.41 million | Fiscal year 2021: $490.49 million | Fiscal year 2020: $298.85 million | Fiscal year 2019: $245.89 million | Fiscal year 2018: $146.31 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: